Nondisabling relapses that occur early in the course of relapsing-remitting multiple sclerosis (RRMS) signal faster accumulation of disability relative to no early relapses, new research suggests ...

Fenebrutinib significantly reduced new lesions with active inflammation in people with relapsing MS in a Phase 2 trial.

A recent dual-cohort study has found that Lupus Low Disease Activity State (LLDAS) is an attainable and effective treatment ...

Relapses are characteristic of relapsing-remitting MS (RRMS) — the condition's most common type. Learn what can trigger a relapse and what to expect during one.

Emergency department visits are more likely for MS patients who have comorbidities, aren't on DMTs, or don't have private ...

The authors said belimumab did not spark statistically significant benefits either in terms of reducing relapses (1.4 in the 6 months on therapy vs 2.0 in the 6 months before therapy; P =.21) or ...

“We now know that MS relapses are only the tip of the iceberg – something beyond relapses is driving the destructive nature of this debilitating disease,” said Erik Wallstroem, ...

A molecule that helps blood clot may also play a role in multiple sclerosis relapses, researchers report in the May 6 issue of PNAS. The new research may help answer the mystery of why remissions ...

John M. Kane, MD: We’re particularly concerned about patients who experience multiple relapses, because we believe that with each relapse, the illness may not respond as well to treatment as it ...

Late relapses in this study seemed to be associated with a higher risk of death as a result of disease for the whole study population, and there is some suggestion that this is also true when looking ...

Hulkow did not indicate how many relapses she had seen among clients, but according to the American Addiction Center, over 19.7 million Americans aged 12 and older battled a substance use disorder ...